Insider · CIK 0001231617
Raymond Dwek
Files at UTHR (UNITED THERAPEUTICS Corp). First filing Apr 8, 2025, latest Apr 22, 2025.
In brief
Raymond Dwek files SEC Form 4 as director at UTHR (UNITED THERAPEUTICS Corp). Since Apr 8, 2025, Raymond Dwek has reported 0 open-market buys worth $0 and 3 open-market sells worth $2.9M, the latest filed on Apr 22, 2025.
A track record needs three past buys with six months of prices behind them; Raymond Dwek has 0, so none is measured yet.
The newest scored trade: sold $857k of UTHR on Apr 21, 2025, filed Apr 22, 2025, scored 31 (weak), under a 10b5-1 plan.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
UTHR: UNITED THERAPEUTICS Corp
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 31Weak | UNITED THERAPEUTICS Corp | $857k 3,000 shares | -63% | +2% from low-31% from high | |
| 31Weak | UNITED THERAPEUTICS Corp | $855k 3,000 shares | -63% | +2% from low-31% from high | |
| 33Weak | UNITED THERAPEUTICS Corp | $1.1M 4,000 shares | -70% | 0% from low-29% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Apr 21, 2025 | UTHR UNITED THERAPEUTICS CORPORATION | 3,000 0.01% of outstanding | $857k | Apr 21, 2025 | $2.0M |
| Apr 14, 2025 | UTHR UNITED THERAPEUTICS CORPORATION | 3,000 0.01% of outstanding | $855k | Apr 14, 2025 | $1.1M |
| Apr 7, 2025 | UTHR UNITED THERAPEUTICS CORPORATION | 4,000 0.01% of outstanding | $1.1M | Apr 7, 2025 | none |
Transactions
Every row this insider has filed, 19 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 24, 2025 | UTHR UNITED THERAPEUTICS Corp | AGrant or award Stock Optionsderivative | +3,650 | $0.00 | $0 | 3,650 | Jul 28, 2025 |
| Apr 21, 2025 | UTHR UNITED THERAPEUTICS Corp | MOption exercise Common Stock10b5-1 | +3,000 | $175.43 | $526k | 4,750 | Apr 22, 2025 |
| Apr 21, 2025 | UTHR UNITED THERAPEUTICS Corp | SOpen-market sale Common Stock10b5-1 | -3,000 | $285.57 | $857k | 1,750 | Apr 22, 2025 |
| Apr 21, 2025 | UTHR UNITED THERAPEUTICS Corp | MOption exercise Stock Optionderivative10b5-1 | -3,000 | $0.00 | $0 | 0 | Apr 22, 2025 |
| Apr 14, 2025 | UTHR UNITED THERAPEUTICS Corp | MOption exercise Common Stock10b5-1 | +3,000 | $175.43 | $526k | 4,750 | Apr 15, 2025 |
| Apr 14, 2025 | UTHR UNITED THERAPEUTICS Corp | SOpen-market sale Common Stock10b5-1 | -3,000 | $285.16 | $855k | 1,750 | Apr 15, 2025 |
| Apr 14, 2025 | UTHR UNITED THERAPEUTICS Corp | MOption exercise Stock Optionderivative10b5-1 | -3,000 | $0.00 | $0 | 3,000 | Apr 15, 2025 |
| Apr 7, 2025 | UTHR UNITED THERAPEUTICS Corp | MOption exercise Common Stock10b5-1 | +4,000 | $175.43 | $702k | 5,750 | Apr 8, 2025 |
| Apr 7, 2025 | UTHR UNITED THERAPEUTICS Corp | SOpen-market sale Common Stock10b5-1 | -4,000 | $284.55 | $1.1M | 1,750 | Apr 8, 2025 |
| Apr 7, 2025 | UTHR UNITED THERAPEUTICS Corp | MOption exercise Stock Optionderivative10b5-1 | -4,000 | $0.00 | $0 | 6,000 | Apr 8, 2025 |
| Apr 22, 2024 | UTHR UNITED THERAPEUTICS Corp | MOption exercise Common Stock10b5-1 | +3,000 | $88.03 | $264k | 4,750 | Apr 23, 2024 |
| Apr 22, 2024 | UTHR UNITED THERAPEUTICS Corp | DDisposition to issuer Common Stock10b5-1 | -3,000 | $234.06 | $702k | 1,750 | Apr 23, 2024 |
| Apr 22, 2024 | UTHR UNITED THERAPEUTICS Corp | MOption exercise Share Tracking Awardderivative10b5-1 | -3,000 | $0.00 | $0 | 0 | Apr 23, 2024 |
| Apr 15, 2024 | UTHR UNITED THERAPEUTICS Corp | MOption exercise Common Stock10b5-1 | +3,000 | $88.03 | $264k | 4,750 | Apr 16, 2024 |
| Apr 15, 2024 | UTHR UNITED THERAPEUTICS Corp | DDisposition to issuer Common Stock10b5-1 | -3,000 | $235.08 | $705k | 1,750 | Apr 16, 2024 |
| Apr 15, 2024 | UTHR UNITED THERAPEUTICS Corp | MOption exercise Share Tracking Awardderivative10b5-1 | -3,000 | $0.00 | $0 | 3,000 | Apr 16, 2024 |
| Apr 8, 2024 | UTHR UNITED THERAPEUTICS Corp | MOption exercise Common Stock10b5-1 | +4,000 | $88.03 | $352k | 5,750 | Apr 9, 2024 |
| Apr 8, 2024 | UTHR UNITED THERAPEUTICS Corp | DDisposition to issuer Common Stock10b5-1 | -4,000 | $236.96 | $948k | 1,750 | Apr 9, 2024 |
| Apr 8, 2024 | UTHR UNITED THERAPEUTICS Corp | MOption exercise Share Tracking Awardderivative10b5-1 | -4,000 | $0.00 | $0 | 6,000 | Apr 9, 2024 |
Questions about Raymond Dwek
Answered from the filings on this page, as of the latest one.
Is Raymond Dwek buying or selling?
Not in the last 12 months. Raymond Dwek's latest open-market trade on SEC Form 4 was sold $857k of UTHR on Apr 21, 2025.
How did Raymond Dwek's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Raymond Dwek has 0.
Where does Raymond Dwek file Form 4?
Raymond Dwek has filed Form 4 at UTHR (UNITED THERAPEUTICS Corp). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.